E411(A) Open for men and non childbearing women
Gender: Male and Female
Smoking habit: Non / Ex-smoker only
18 - 55
BMI : 18.00 - 32.00
Food restrictions : Fast
Lonafarnib is being developed to treat chronic hepatitis D virus (HDV) infection.
Dose: 50 mg lonafarnib
Ritonavir is FDA approved to treat human immunodeficiency virus (HIV). It is being used in this study as a booster to increase the concentration of lonafarnib in your body. A booster is a drug that keeps your body from breaking down a drug before it works.
Dose: 100 mg ritonavir
This drug indicated in the treatment of chronic HDV infection.
Women must be of non-childbearing potential.
This is preliminary information and changes could occur without notice